BMO Capital Markets upgraded Ryan Specialty's stock to Outperform from Market Perform, increasing the price target to $75.00. This reflects a positive long-term outlook despite potential short-term challenges such as competition from Marsh & McLennan Companies and Aon (NYSE: AON ). Barclays also initiated coverage on Ryan Specialty Group, assigning it an Overweight rating.